South & Central America Molecular Diagnostics Market Forecast to 2030 – Regional Analysis – by Disease Area (Oncology, Infectious Disease, Genetic Testing, Cardiac Diseases, Immune System Disorders, and Others), Technology (Polymerase Chain Reaction, Isot

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,550	102 Pages	The Insight Partners	January, 2024	TIP18628028

Best Price Guarantee
Price	from $3,550
Length	102 Pages
Publisher	The Insight Partners
Published Date	January, 2024
SKU	TIP18628028

South & Central America Molecular Diagnostics Market Forecast to 2030 – Regional Analysis – by Disease Area (Oncology, Infectious Disease, Genetic Testing, Cardiac Diseases, Immune System Disorders, and Others), Technology (Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, DNA Microarrays, In-Situ Hybridization, and Others), Product and Services (Assays & Kits, Instruments, and Services & Software), and End User (Hospitals & Clinics, Diagnostic Laboratories, Research & Academic Institutes, and Others)The South & Central America molecular diagnostics market is expected to grow from US$ 1,221.28 million in 2022 to US$ 2,679.14 million by 2030. It is estimated to grow at a CAGR of 10.3% from 2022 to 2030.

Advancements in Molecular Diagnostics Technologies Fuels South & Central America Molecular Diagnostics Market

Molecular diagnostic techniques and platforms are being used in all areas of anatomic and clinical pathologies. DNA or RNA sequences that are associated with disease, including single nucleotide polymorphism, deletions, rearrangements, and insertions, can be detected in molecular diagnostic tests. Molecular diagnosis has undergone further improvements after the emergence of COVID-19. Conventionally, CT scans, hematological tests, and RT-PCR were in use for testing. As COVID-19 cases grew rapidly in 2020, the need for rapid, precise testing platforms surged to overcome the disadvantages of conventional testing. Computed tomography (CT), a cost-intensive procedure that may not be available in all hospitals, fails to detect viral infections and other diseases in asymptomatic patients. RT-PCR, which was widely used, was also time-consuming and expensive, and was unable to detect a low viral load during the early stages of infection. Consequently, researchers developed novel approaches to detect SARS-CoV-2, which were faster and more cost effective. Reverse transcription loop-mediated isothermal amplification (RT-LAMP), microarray-based detection, aptamer-based diagnosis, SHERLOCK, SHERLOCKv2, FET Biosensors, cell-based potentiometric diagnosis, and molecular imprinting technology are a few of the examples of novel molecular diagnostics techniques developed for COVID-19 diagnosis. In the last few years, FDA reports have indicated that advancements in molecular testing, antigen-dependent testing, and serological testing have been approved. Collaborative efforts by scientific communities in different countries to manage the COVID-19 pandemic and reduce the extent of mortality have benefited the overall molecular tools and diagnosis landscape, which is likely to create significant opportunities for the molecular diagnostics market in the future.

South & Central America Molecular Diagnostics Market Overview

The molecular diagnostics market in South & Central America is segmented into Argentina, Brazil, and the Rest of South & Central America. The market growth in the region is attributed to the aging population, growing diagnostics market, and the increasing initiatives by major players in the medical device industry. Furthermore, the prevalence of chronic diseases that demand promising diagnostic test options contributes to the market growth in the region.

South & Central America Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Molecular Diagnostics Market Segmentation

The South & Central America molecular diagnostics market is segmented into disease area, technology, product and services, end user, and country.

Based on disease area, the South & Central America molecular diagnostics market is segmented into infectious disease, oncology, genetic testing, cardiac diseases, immune system disorders, and others. The infectious disease segment registered the largest South & Central America molecular diagnostics market share in 2022.

Based on technology, the South & Central America molecular diagnostics market is segmented into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), DNA sequencing and next-generation sequencing (NGS), DNA microarrays, and others. The polymerase chain reaction (PCR) segment registered the largest South & Central America molecular diagnostics market share in 2022. The polymerase chain reaction (PCR) is further sub segmented into RT-PCR, qPCR, multiplex PCR, and others.

Based on product and services, the South & Central America molecular diagnostics market is segmented into assays and kits, instruments, and services and software. The assays and kits segment registered the largest South & Central America molecular diagnostics market share in 2022.

Based on end users, the South & Central America molecular diagnostics market is segmented into diagnostic laboratories, hospitals and clinics, research and academic institutes, and others. The diagnostic laboratories segment held the largest South & Central America molecular diagnostics market share in 2022.

Based on country, the South & Central America molecular diagnostics market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America molecular diagnostics market in 2022.

Abbott Laboratories, bioMerieux SA, Danaher, F. Hoffmann-La Roche Ltd, Illumina Inc, Novartis AG, Qiagen NV, Siemens Healthineers AG, and Thermo Fisher Scientific Inc. are some of the leading companies operating in the South & Central America molecular diagnostics market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America molecular diagnostics market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the South & Central America molecular diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the molecular diagnostics market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Introduction: 1.1 The Insight Partners Research Report Guidance; 1.2 Market Segmentation
2. Executive Summary: 2.1 Key Insights
3. Research Methodology: 3.1 Coverage; 3.2 Secondary Research; 3.3 Primary Research
4. South & Central America Molecular Diagnostics Market Landscape: 4.1 Overview; 4.2 PEST Analysis; 4.2.1 South & Central America PEST Analysis
5. South & Central America Molecular Diagnostics Market - Key Industry Dynamics: 5.1 Key Market Drivers:; 5.1.1 Development of New Products and Increase in Demand for Point-of-Care Testing; 5.1.2 Surging Prevalence of Associated Diseases; 5.2 Market Restraints; 5.2.1 Limitations Associated with Molecular Testing; 5.3 Market Opportunities; 5.3.1 Advancements in Molecular Diagnostics Technologies; 5.4 Future Trends; 5.4.1 Molecular Diagnostics in Personalized Medicine; 5.5 Impact Analysis:
6. Molecular Diagnostics Market - South & Central America Market Analysis: 6.1 South & Central America Molecular Diagnostics Market Revenue (US$ Mn), 2022 – 2030
7. South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Disease Area: 7.1 Overview; 7.2 South & Central America Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%); 7.3 Oncology; 7.3.1 Overview; 7.3.2 Oncology: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 7.4 Infectious Disease; 7.4.1 Overview; 7.4.2 Infectious Disease: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 7.5 Genetic Testing; 7.5.1 Overview; 7.5.2 Genetic Testing: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 7.6 Cardiac Diseases; 7.6.1 Overview; 7.6.2 Cardiac Diseases: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 7.7 Immune System Disorders; 7.7.1 Overview; 7.7.2 Immune System Disorders: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 7.8 Others; 7.8.1 Overview; 7.8.2 Others: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Technology: 8.1 Overview; 8.2 South & Central America Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%); 8.3 Polymerase Chain Reaction; 8.3.1 Overview; 8.3.2 PCR: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 8.3.2.1 RT-PCR; 8.3.2.1.1 Overview; 8.3.3 RT-PCR: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 8.3.3.1 qPCR; 8.3.3.1.1 Overview; 8.3.4 qPCR: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 8.3.4.1 Multiplex PCR; 8.3.4.1.1 Overview; 8.3.5 Multiplex PCR: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 8.3.5.1 Others; 8.3.5.1.1 Overview; 8.3.6 Others: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 8.4 Isothermal Nucleic Acid Amplification Technology (INAAT); 8.4.1 Overview; 8.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT): South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 8.5 DNA Sequencing and Next-Generation Sequencing (NGS); 8.5.1 Overview; 8.5.2 DNA Sequencing and Next-Generation Sequencing (NGS): South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 8.6 DNA Microarrays; 8.6.1 Overview; 8.6.2 DNA Microarrays: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 8.7 In-Situ Hybridization (ISH); 8.7.1 Overview; 8.7.2 In-Situ Hybridization (ISH): South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 8.8 Others; 8.8.1 Overview; 8.8.2 Others: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Product and Services: 9.1 Overview; 9.2 South & Central America Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%); 9.3 Assays and Kits; 9.3.1 Overview; 9.3.2 Assays and Kits: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 9.4 Instruments; 9.4.1 Overview; 9.4.2 Instruments: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 9.5 Services and Software; 9.5.1 Overview; 9.5.2 Services and Software: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 – by End User: 10.1 Overview; 10.2 South & Central America Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%); 10.3 Hospitals and Clinics; 10.3.1 Overview; 10.3.2 Hospitals and Clinics: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 10.4 Diagnostics Laboratories; 10.4.1 Overview; 10.4.2 Diagnostics Laboratories: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 10.5 Research and Academic Institutes; 10.5.1 Overview; 10.5.2 Research and Academic Institutes: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 10.6 Others; 10.6.1 Overview; 10.6.2 Others: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11. South & Central America Molecular Diagnostics Market - Country Analysis: 11.1 South & Central America Molecular Diagnostics Market, Revenue and Forecast to 2030; 11.1.1 Overview; 11.1.1.1 South & Central America Molecular Diagnostics Market by Country; 11.1.2 Brazil; 11.1.2.1 Overview; 11.1.3 Brazil: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn); 11.1.4 Brazil: Molecular Diagnostics Market, by Disease Area; 11.1.5 Brazil: Molecular Diagnostics Market, by Technology; 11.1.5.1 Brazil: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR); 11.1.6 Brazil: Molecular Diagnostics Market, by Product and Services; 11.1.7 Brazil: Molecular Diagnostics Market, by End User; 11.1.8 Argentina; 11.1.8.1 Overview; 11.1.9 Argentina: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn); 11.1.10 Argentina: Molecular Diagnostics Market, by Disease Area; 11.1.11 Argentina: Molecular Diagnostics Market, by Technology; 11.1.11.1 Argentina: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR); 11.1.12 Argentina: Molecular Diagnostics Market, by Product and Services; 11.1.13 Argentina: Molecular Diagnostics Market, by End User; 11.1.14 Rest of South & Central America; 11.1.14.1 Overview; 11.1.15 Rest of South & Central America: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn); 11.1.16 Rest of South & Central America Molecular Diagnostics Market, by Disease Area; 11.1.17 Rest of South & Central America Molecular Diagnostics Market, by Technology; 11.1.17.1 Rest of South & Central America: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR); 11.1.18 Rest of South & Central America: Molecular Diagnostics Market, by Product and Services; 11.1.19 Rest of South & Central America: Molecular Diagnostics Market, by End User
12. South & Central America Molecular Diagnostics Market Industry Landscape: 12.1 Overview; 12.2 Growth Strategies Done by the Companies in the Market (%); 12.3 Organic Developments; 12.3.1 Overview; 12.4 Inorganic Developments; 12.4.1 Overview
13. South & Central America Molecular Diagnostics Market, Key Company Profiles: 13.1 Abbott Laboratories; 13.1.1 Key Facts; 13.1.2 Business Description; 13.1.3 Products and Services; 13.1.4 Financial Overview; 13.1.5 SWOT Analysis; 13.1.6 Key Developments; 13.2 Thermo Fisher Scientific Inc; 13.2.1 Key Facts; 13.2.2 Business Description; 13.2.3 Products and Services; 13.2.4 Financial Overview; 13.2.5 SWOT Analysis; 13.2.6 Key Developments; 13.3 F. Hoffmann-La Roche Ltd; 13.3.1 Key Facts; 13.3.2 Business Description; 13.3.3 Products and Services; 13.3.4 Financial Overview; 13.3.5 SWOT Analysis; 13.3.6 Key Developments; 13.4 Qiagen NV; 13.4.1 Key Facts; 13.4.2 Business Description; 13.4.3 Products and Services; 13.4.4 Financial Overview; 13.4.5 SWOT Analysis; 13.4.6 Key Developments; 13.5 bioMerieux SA; 13.5.1 Key Facts; 13.5.2 Business Description; 13.5.3 Products and Services; 13.5.4 Financial Overview; 13.5.5 SWOT Analysis; 13.5.6 Key Developments; 13.6 Illumina Inc; 13.6.1 Key Facts; 13.6.2 Business Description; 13.6.3 Products and Services; 13.6.4 Financial Overview; 13.6.5 SWOT Analysis; 13.6.6 Key Developments; 13.7 Danaher; 13.7.1 Key Facts; 13.7.2 Business Description; 13.7.3 Products and Services; 13.7.4 Financial Overview; 13.7.5 SWOT Analysis; 13.7.6 Key Developments; 13.8 Siemens Healthineers AG; 13.8.1 Key Facts; 13.8.2 Business Description; 13.8.3 Products and Services; 13.8.4 Financial Overview; 13.8.5 SWOT Analysis; 13.8.6 Key Developments; 13.9 Novartis AG; 13.9.1 Key Facts; 13.9.2 Business Description; 13.9.3 Products and Services; 13.9.4 Financial Overview; 13.9.5 SWOT Analysis; 13.9.6 Key Developments
14. Appendix: 14.1 About Us; 14.2 Glossary of Terms
LIST OF TABLES: Table 1. South & Central America Molecular Diagnostics Market Segmentation; Table 2. Brazil: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) – Disease Area; Table 3. Brazil: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) – Technology; Table 4. Brazil: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR); Table 5. Brazil: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) – Product and Services; Table 6. Brazil: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) – End User; Table 7. Argentina: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) – Disease Area; Table 8. Argentina: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) – Technology; Table 9. Argentina: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR); Table 10. Argentina: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) – Product and Services; Table 11. Argentina: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) – End User; Table 12. Rest of South & Central America: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) – Disease Area; Table 13. Rest of South & Central America: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) – Technology; Table 14. Rest of South & Central America: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR); Table 15. Rest of South & Central America: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services; Table 16. Rest of South & Central America: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User; Table 17. Organic Developments Done By Companies; Table 18. Inorganic Developments Done By Companies; Table 19. Glossary of Terms, Molecular Diagnostics Market
LIST OF FIGURES: Figure 1. South & Central America - PEST Analysis; Figure 2. South & Central America Molecular Diagnostics Market - Key Industry Dynamics; Figure 3. Impact Analysis of Drivers and Restraints; Figure 4. South & Central America Molecular Diagnostics Market Revenue (US$ Mn), 2022 – 2030; Figure 5. South & Central America Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%); Figure 6. Oncology: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 7. Infectious Disease: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 8. Genetic Testing: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 9. Cardiac Diseases: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 10. Immune System Disorders: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 11. Others: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 12. South & Central America Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%); Figure 13. PCR: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 14. RT-PCR: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 15. qPCR: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 16. Multiplex PCR: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 17. Others: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 18. Isothermal Nucleic Acid Amplification Technology (INAAT): South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 19. DNA Sequencing and Next-Generation Sequencing (NGS): South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 20. DNA microarrays: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 21. In-Situ Hybridization (ISH): South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 22. Others: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 23. South & Central America Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%); Figure 24. Assays and Kits: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 25. Instruments: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 26. Services and Software: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 27. South & Central America Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%); Figure 28. Hospitals and Clinics: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 29. Ambulatory Surgical Centers: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 30. Research and Academic Institutes: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 31. Others: South & Central America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 32. Molecular Diagnostics Market, By Country, 2022 (US$ Mn); Figure 33. South & Central America Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%); Figure 34. Brazil: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn); Figure 35. Argentina: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn); Figure 36. Rest of South & Central America: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn); Figure 37. Growth Strategies Done by the Companies in the Market (%)